The clinical presentation and treatment of MOG antibody disease at a single academic center: A case series.
J Neuroimmunol
; 337: 577078, 2019 12 15.
Article
em En
| MEDLINE
| ID: mdl-31671362
ABSTRACT
OBJECTIVES:
To describe the clinical presentation of MOG antibody disease (MOG-AD) in a series of patients at a single academic center.METHODS:
We performed a retrospective review of patients with MOG antibodies.RESULTS:
We review the clinical presentation of 11 patients with MOG antibodies. In patients seen at Duke University Health System with MOG antibodies, the most common presentation was optic neuritis. Rituximab was the most used treatment for long-term management.CONCLUSIONS:
Our case series highlights the common presentation of MOG antibody disease (MOG-AD) at a single academic medical center.Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Autoanticorpos
/
Neurite Óptica
/
Centros Médicos Acadêmicos
/
Glicoproteína Mielina-Oligodendrócito
/
Rituximab
/
Fatores Imunológicos
Idioma:
En
Ano de publicação:
2019
Tipo de documento:
Article